{"id":948741,"date":"2026-04-02T11:26:44","date_gmt":"2026-04-02T15:26:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/"},"modified":"2026-04-02T11:26:44","modified_gmt":"2026-04-02T15:26:44","slug":"investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/","title":{"rendered":"INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit \u2013 RGRD Law"},"content":{"rendered":"
\n

SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP<\/strong><\/a> announces that purchasers or acquirers of Boston Scientific Corporation (NYSE: BSX) common stock between July 23, 2025 and February 3, 2026, all dates inclusive (the \u201cClass Period\u201d), have until May 4, 2026 to seek appointment as lead plaintiff of the Boston Scientific <\/em>class action lawsuit. Captioned Troike v. Boston Scientific Corporation<\/em>, No. 26-cv-40075 (D. Mass.), the Boston Scientific <\/em>class action lawsuit charges Boston Scientific as well as certain of Boston Scientific\u2019s top executives with violations of the Securities Exchange Act of 1934.<\/p>\n

\n If you suffered substantial losses and wish to serve as lead plaintiff of the <\/strong>
\n
\n Boston Scientific <\/em>
\n <\/strong>
\n class action lawsuit, please provide your information here:<\/strong>\n <\/p>\n

\n
\n https:\/\/www.rgrdlaw.com\/cases-boston-scientific-corporation-class-action-lawsuit-bsx.html<\/strong>
\n <\/a>\n <\/p>\n

\n You can also contact attorney <\/strong>
\n
\n J.C. Sanchez<\/strong>
\n <\/a>
\n of Robbins Geller by calling 800\/449-4900 or via e-mail at <\/strong>
\n
\n info@rgrdlaw.com<\/strong>
\n <\/a>
\n .<\/strong>\n <\/p>\n

\n CASE ALLEGATIONS<\/strong>: Boston Scientific develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.<\/p>\n

The Boston Scientific <\/em>class action lawsuit alleges that defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: (i) defendants created the false impression that they possessed reliable information pertaining to Boston Scientific\u2019s projected revenue outlook and anticipated growth while also minimizing risk from seasonality and macroeconomic fluctuations; and (ii) Boston Scientific\u2019s ambition of continuing \u201cto grow our share in the overall EP market\u201d to maintain a growth trajectory at \u201c2x the market\u201d had fallen short of reality because Boston Scientific had begun to experience new competition entrants that were sapping Boston Scientific\u2019s U.S. Electrophysiology market share and thus limiting its growth potential.<\/p>\n

The Boston Scientific<\/em> class action lawsuit further alleges that on February 4, 2026, Boston Scientific announced fourth quarter and full year 2025 financial results, disclosing that: (i) in the fourth quarter 2025, Boston Scientific reported \u201cGAAP net income attributable to Boston Scientific common stockholders of $672 million or $0.45 per share (EPS), compared to $566 million or $0.38 per share a year ago, and achieved adjusted EPS of $0.80 for the period, compared to $0.70 a year ago\u201d; (ii) Boston scientific \u201creported GAAP net income attributable to Boston Scientific common stockholders of $2.898 billion or $1.94 per share, compared to $1.853 billion or $1.25 per share a year ago, and delivered full year adjusted EPS of $3.06, compared to $2.51 a year ago\u201d; and (iii) Boston Scientific \u201c[r]eported GAAP net income attributable to Boston Scientific common stockholders of $0.45 per share, compared to the company’s guidance range of $0.48 to $0.52 per share.\u201d On this news, the price of Boston Scientific common stock fell more than 17%, according to the complaint.<\/p>\n

\n THE LEAD PLAINTIFF PROCESS<\/strong>: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Boston Scientific common stock during the Class Period to seek appointment as lead plaintiff in the Boston Scientific <\/em>class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Boston Scientific <\/em>investor class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Boston Scientific <\/em>shareholder class action lawsuit. An investor\u2019s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Boston Scientific <\/em>class action lawsuit.<\/p>\n

\n ABOUT ROBBINS GELLER: <\/strong>Robbins Geller Rudman & Dowd LLP is one of the world\u2019s leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors \u2013 $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs\u2019 firms in the world, and the Firm\u2019s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever \u2013 $7.2 billion \u2013 in In re Enron Corp. Sec. Litig.<\/em> Please visit the following page for more information:<\/p>\n

\n
\n https:\/\/www.rgrdlaw.com\/services-litigation-securities-fraud.html<\/strong>
\n <\/a>\n <\/p>\n

Past results do not guarantee future outcomes.\u00a0
Services may be performed by attorneys in any of our offices.\u00a0<\/p>\n

Contact:
Robbins Geller Rudman & Dowd LLP
J.C. Sanchez
655 W. Broadway, Suite 1900, San Diego, CA 92101
800-449-4900
info@rgrdlaw.com<\/strong><\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Boston Scientific Corporation (NYSE: BSX) common stock between July 23, 2025 and February 3, 2026, all dates inclusive (the \u201cClass Period\u201d), have until May 4, 2026 to seek appointment as lead plaintiff of the Boston Scientific class action lawsuit. Captioned Troike v. Boston Scientific Corporation, No. 26-cv-40075 (D. Mass.), the Boston Scientific class action lawsuit charges Boston Scientific as well as certain of Boston Scientific\u2019s top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Boston Scientific class action lawsuit, please provide your information here: … <\/p>\n

Continue reading “INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit \u2013 RGRD Law”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-948741","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nINVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit \u2013 RGRD Law - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit \u2013 RGRD Law - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Boston Scientific Corporation (NYSE: BSX) common stock between July 23, 2025 and February 3, 2026, all dates inclusive (the \u201cClass Period\u201d), have until May 4, 2026 to seek appointment as lead plaintiff of the Boston Scientific class action lawsuit. Captioned Troike v. Boston Scientific Corporation, No. 26-cv-40075 (D. Mass.), the Boston Scientific class action lawsuit charges Boston Scientific as well as certain of Boston Scientific\u2019s top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Boston Scientific class action lawsuit, please provide your information here: … Continue reading "INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit \u2013 RGRD Law"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-02T15:26:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MTc5NiM3NTEzMTI4IzIxMzY1Nzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit \u2013 RGRD Law\",\"datePublished\":\"2026-04-02T15:26:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/\"},\"wordCount\":751,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MTc5NiM3NTEzMTI4IzIxMzY1Nzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/\",\"name\":\"INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit \u2013 RGRD Law - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MTc5NiM3NTEzMTI4IzIxMzY1Nzk=\",\"datePublished\":\"2026-04-02T15:26:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MTc5NiM3NTEzMTI4IzIxMzY1Nzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MTc5NiM3NTEzMTI4IzIxMzY1Nzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit \u2013 RGRD Law\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit \u2013 RGRD Law - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/","og_locale":"en_US","og_type":"article","og_title":"INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit \u2013 RGRD Law - Market Newsdesk","og_description":"SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Boston Scientific Corporation (NYSE: BSX) common stock between July 23, 2025 and February 3, 2026, all dates inclusive (the \u201cClass Period\u201d), have until May 4, 2026 to seek appointment as lead plaintiff of the Boston Scientific class action lawsuit. Captioned Troike v. Boston Scientific Corporation, No. 26-cv-40075 (D. Mass.), the Boston Scientific class action lawsuit charges Boston Scientific as well as certain of Boston Scientific\u2019s top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Boston Scientific class action lawsuit, please provide your information here: … Continue reading \"INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit \u2013 RGRD Law\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-02T15:26:44+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MTc5NiM3NTEzMTI4IzIxMzY1Nzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit \u2013 RGRD Law","datePublished":"2026-04-02T15:26:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/"},"wordCount":751,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MTc5NiM3NTEzMTI4IzIxMzY1Nzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/","name":"INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit \u2013 RGRD Law - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MTc5NiM3NTEzMTI4IzIxMzY1Nzk=","datePublished":"2026-04-02T15:26:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MTc5NiM3NTEzMTI4IzIxMzY1Nzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MTc5NiM3NTEzMTI4IzIxMzY1Nzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-deadline-boston-scientific-corporation-bsx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit \u2013 RGRD Law"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/948741","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=948741"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/948741\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=948741"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=948741"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=948741"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}